Effect of opioid receptor antagonism on proopiomelanocortin peptide levels and gene expression in the hypothalamus
- 30 June 1992
- journal article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 3 (3) , 184-190
- https://doi.org/10.1016/1044-7431(92)90037-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- INDUCTION OF OVULATION BY THE CHRONIC ADMINISTRATION OF NALTREXONE IN HYPOTHALAMIC AMENORRHEAJournal of Clinical Endocrinology & Metabolism, 1987
- Opioids Act Centrally to Modulate Stress-Induced Decrease in Luteinizing Hormone in the Rat*Endocrinology, 1986
- Endogenous Opioid Peptides and Hypothalamo-Pituitary FunctionAnnual Review of Physiology, 1986
- Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretionAmerican Journal of Obstetrics and Gynecology, 1985
- Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.Journal of Clinical Investigation, 1984
- Endogenous Opioids: Biology and FunctionAnnual Review of Neuroscience, 1984
- Effect of Chronic Naltrexone and Methadone Administration on Brain Immunoreactive β-Endorphin in the RatNeuroendocrinology, 1983
- Effect of Endogenous Opioid Blockade on the Amplitude and Frequency of Pulsatile Luteinizing Hormone Secretion in Normal Men*Journal of Clinical Endocrinology & Metabolism, 1982
- THE ROLE OF ENDOGENOUS OPIATES ON LH SECRETION DURING THE MENSTRUAL CYCLEJournal of Clinical Endocrinology & Metabolism, 1980
- Endogenous Opioids Participate in the Regulation of the Hypothalamic-Pituitary-Luteinizing Hormone Axis and Testosterone's Negative Feedback Control of Luteinizing Hormone*Endocrinology, 1979